73219-89-3

Usage

Uses

Used in Organic Synthesis:
3-BROMO-2,6-DIMETHOXYBENZOIC ACID is used as a building block for the synthesis of new chemical compounds with specific properties, contributing to the development of novel materials and substances in various fields.
Used in Pharmaceutical Industry:
3-BROMO-2,6-DIMETHOXYBENZOIC ACID is used as a research and development compound for its potential applications in the pharmaceutical industry, where it may contribute to the discovery of new drugs or therapeutic agents.
Used in Agrochemical Industry:
3-BROMO-2,6-DIMETHOXYBENZOIC ACID is used as a research compound in the agrochemical industry, where it may be explored for its potential to develop new agrochemicals or enhance existing ones.
Used in Biological Research:
3-BROMO-2,6-DIMETHOXYBENZOIC ACID is used as a subject of study in biological research for its potential biological activities and effects, such as antifungal and antimicrobial properties, which could lead to applications in medicine or agriculture.

InChI:InChI=1/C9H9BrO4/c1-13-6-4-3-5(10)8(14-2)7(6)9(11)12/h3-4H,1-2H3,(H,11,12)

Upstream product

• 65977-12-0 3-Brom-2,6-dimethoxy-benzoesaeure-methylester 
• 1466-76-8 2-6-dimethoxybenzoic acid 

Downstream Products

• 84225-91-2 5-bromo-2,6-dimethoxybenzoic acid chloride 
• 73219-92-8 3-bromo-5-chloro-2,6-dimethoxybenzoic acid 
• 80125-14-0 remoxipride 
• 84225-93-4 (-)-N-n-propyl-2-(3-bromo-2,6-dimethoxybenzamidomethyl)pyrrolidine 
• 73219-94-0 N-Ethyl-2-(3-bromo-2,6-dimethoxybenzamidomethyl)pyrrolidine hydrochloride 
• 206348-24-5 (3-bromo-2,6-dimethoxyphenyl)(furan-2-yl)methanone 
• 1600514-96-2 (3-bromo-2,6-dimethoxyphenyl)(pyridin-3-yl)methanone 
• 1600514-88-2 1-(3-bromo-2,6-dimethoxyphenyl)-2-phenylethanone 
• 1600514-91-7 1-(3-bromo-2,6-dimethoxyphenyl)-2-(4-bromophenyl)ethanone 

Relevant academic research and scientific papers

New anthracene derivatives from Coussarea macrophylla

Five new naturally occurring anthracene derivatives, 1,4,10-trimethoxyanthracene-2-carbaldehyde (1), (1,4,10-trimethoxy-2-anthracen-2-yl)methanol (2), 1,4,8,10-tetramethoxyanthracene-2-carbaldehyde (3), 1,4,10-trimethoxyanthracene-2-carboxylic acid (4), a

Process for aromatic bromination

A novel procedure for bromination of aromatic moieties utilizes N-bromosuccinimide or dibromodimethylhydantoin in an aqueous alkali medium. The bromination procedure is employed for the preparation of an intermediate used in the preparation of remoxipride, an antipsychotic compound.

N-bromosuccinimide/dibromodimethylhydantoin in aqueous base: A practical method for the bromination of activated benzoic acids

A new bromination method employing NBS or dibromodimethylhydantoin in aqueous base is described for the synthesis of 3-bromo-2,6-dimethoxybenzoic acid (1) and other monobrominated alkoxybenzoic acids.

Chromatographic Separation of Enantiomers and Barriers to Enantiomerization of Axially Chiral Aromatic Carboxamides

The enantiomers (M) and (P) of a series of similar aromatic carboxamides have been, for the first time, investigated analytically and enriched preparatively by liquid chromatography on triacetylcellulose.Enantiomeric purities (7-99percent), specific rotations, and barriers to rotation about the C(sp2)-C(sp2) bond (87 - 120 kJ/mol, Table 5) were determined.These energies are discussed in terms of the size of ortho substituents and of the buttressing effects by meta substituents.

Potential Neuroleptic Agents. 2,6-Dialkoxybenzamide Derivatives with Potent Dopamine Receptor Blocking Activities

A series of some novel N-(1-ethyl-2-pyrrolidinylmethyl)benzamides was synthesized and tested for dopamine receptor blockade in vivo by the ability to block the apomorphine syndrome in the rat.Several compounds were considerably more potent than sulpiride as dopamine receptor blockers and displayed low liability to induce extrapyramidal side effects (catalepsy) in the rat.The blockade of dopamine receptor activity in vivo was mainly confined to the levorotatory isomers having the S absolute configuration.The structure-activity relationships are discussed.

2,6-Dialkoxybenzamides, intermediates, pharamaceutical compositions and methods for treatment of psychotic disorders

A compound of the formula, wherein R1 is an alkyl group with 1-3 carbon atoms, R2 and R3 are the same or different and each is hydrogen, chlorine or bromine; and pharmaceutically acceptable salts and optical isomers thereof; methods and intermediates for